Observational Retrospective Cohort of Patient Support Program Data on Practical Experiences of Treatment with Foslevodopa/Foscarbidopa in Advanced Parkinson’s Disease: The ORCHESTRA Study

Tobias Warnecke, Anton Adriaan Van der Plas, Petra Schwingenschuh, Anders Johansson, Mihaela Simu, Marie O’Meara, Resmi Gupta, Bjoern Fritz, Lars Bergmann, Juan Carlos Parra, Martin Südmeyer · 2026

Read Observational Retrospective Cohort of Patient Support Program Data on Practical Experiences of Treatment with Foslevodopa/Foscarbidopa in Advanced Parkinson’s Disease: The ORCHESTRA Study by Tobias Warnecke, Anton Adriaan Van der Plas, Petra Schwingenschuh, Anders Johansson, Mihaela Simu, Marie O’Meara, Resmi Gupta, Bjoern Fritz, Lars Bergmann, Juan Carlos Parra, Martin Südmeyer (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13396073.txt.

Description

Tobias Warnecke and colleagues report everyday experience with a round-the-clock under-skin infusion for advanced Parkinson's disease, drawn from a company patient support program. The 2026 ORCHESTRA study covers 2,590 patients in several countries who began the treatment between December 2023 and February 2025.

Nurses recorded doses, handling, and symptoms during routine contacts rather than set visits. The infusion rate settled within about five days and then held steady. In the first month after tuning, 60 percent of those with data reported no daily off time, when medicine fades, and 83 percent reported no unwanted movements. Skin problems at the infusion site were the top reason for stopping, at 5.1 percent.

Catalog record

CREATORTobias Warnecke, Anton Adriaan Van der Plas, Petra Schwingenschuh, Anders Johansson, Mihaela Simu, Marie O’Meara, Resmi Gupta, Bjoern Fritz, Lars Bergmann, Juan Carlos Parra, Martin Südmeyer
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE77925
LICENSEhttps://creativecommons.org/licenses/by/4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/article/MED/PMC13396073

Browse the full library · About the Tower of Babel